The Usefulness of Tubulin Beta 3 (TUBB3) in Distinguishing Reactive Follicular Hyperplasia From Follicular Lymphoma: Results from an Extended Series Including In Situ Follicular Lymphoma

被引：0
|
作者：
Zamo, Alberto [1 ]
Erdini, Francesco [1 ]
Chilosi, Marco [1 ]
机构：
[1] Univ Verona, I-37100 Verona, Italy
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1555
引用
收藏
页码：390A / 391A
页数：2
相关论文
共 50 条
  • [41] AN ULTRASTRUCTURAL MORPHOMETRIC STUDY OF FOLLICULAR CENTER LYMPHOCYTES .3. THE CONTROL OF LYMPHOCYTE NUCLEAR SIZE IN REACTIVE HYPERPLASIA AND NON-HODGKINS-LYMPHOMA
    DARDICK, I
    MOHER, D
    CAVELL, S
    DARDICK, A
    BURNS, BF
    COLLINGWOOD, K
    FULCHER, RG
    MODERN PATHOLOGY, 1990, 3 (02) : 176 - 185
  • [42] IMMUNOHISTOCHEMICAL DISTINCTION OF FOLLICULAR LYMPHOMA FROM FOLLICULAR HYPERPLASIA IN FORMALIN-FIXED TISSUES USING MONOCLONAL-ANTIBODIES MT2 AND BCL-2
    VELOSO, JD
    REZUKE, WN
    CARTUN, RW
    ABERNATHY, EC
    PASTUSZAK, WT
    APPLIED IMMUNOHISTOCHEMISTRY, 1995, 3 (03): : 153 - 159
  • [43] IMMUNOCYTOCHEMICAL DIFFERENTIATION OF REACTIVE HYPERPLASIA FROM FOLLICULAR LYMPHOMA USING MONOCLONAL-ANTIBODIES TO CELL-SURFACE AND PROLIFERATION-RELATED MARKERS
    WOOD, B
    BACCHI, MM
    BACCHI, CE
    KIDD, PG
    GOWN, AM
    LABORATORY INVESTIGATION, 1993, 68 (01) : A103 - A103
  • [44] IMMUNOCYTOCHEMICAL DIFFERENTIATION OF REACTIVE HYPERPLASIA FROM FOLLICULAR LYMPHOMA USING MONOCLONAL-ANTIBODIES TO CELL-SURFACE AND PROLIFERATION-RELATED MARKERS
    WOOD, BL
    BACCHI, MM
    BACCHI, CE
    KIDD, P
    GOWN, AM
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 1994, 2 (01) : 48 - 53
  • [45] Sclerosing variant of follicular lymphoma arising from submandibular glands and resembling "Kuttner tumor": A report of 3 patients
    Kojima, M
    Nakamura, S
    Itoh, H
    Yamane, Y
    Tanaka, H
    Sugihara, S
    Sakata, N
    Masawa, N
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2003, 11 (04) : 303 - 307
  • [46] Safety in Patients Receiving Maintenance Rituximab for Follicular Lymphoma: Results from Phase IIIb MAXIMA Trial
    Witzens-Harig, Mathias
    Hipp, Joachim
    Ho, Anthony D.
    Nikolov, Nikolai
    Thurley, Daniel
    Hensel, Manfred
    Oertel, Stefan
    Wenger, Michael
    BLOOD, 2008, 112 (11) : 697 - 697
  • [47] Safety in patients receiving maintenance rituximab for follicular lymphoma: Results from the phase IIIb MAXIMA trial
    Wenger, M. K.
    Foa, R.
    Arcaini, L.
    Vranovsky, A.
    Ivanova, V.
    Van Hazel, G. A.
    Kurtovic, S.
    Duran, S.
    Gamba, E.
    Thurley, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic BCL-2 and cell surface CD20.
    Cornfield, DB
    Mitchell, DM
    Almasri, NM
    Anderson, JB
    Ahrens, KP
    Dooley, EO
    Braylan, RC
    BLOOD, 1999, 94 (10) : 83A - 83A
  • [49] Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20
    Cornfield, DB
    Mitchell, DM
    Almasri, NM
    Anderson, JB
    Ahrens, KP
    Dooley, EO
    Braylan, RC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) : 258 - 263
  • [50] Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis
    Arends, JE
    Bot, FJ
    Gisbertz, IAM
    Schouten, HC
    HISTOPATHOLOGY, 1999, 35 (03) : 209 - 215
12345